This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 2010
Title
Histone deacetylase inhibition leads to Spermatocyte depletion
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
---|---|---|---|---|---|---|
Histone deacetylase inhibition leading to testicular atrophy | non-adjacent | Moderate | Moderate | Brendan Ferreri-Hanberry (send email) | Open for citation & comment | WPHA/WNT Endorsed |
Taxonomic Applicability
Term | Scientific Term | Evidence | Link |
---|---|---|---|
rat | Rattus norvegicus | High | NCBI |
Sex Applicability
Sex | Evidence |
---|---|
Male | High |
Life Stage Applicability
Term | Evidence |
---|---|
Adult, reproductively mature | Moderate |
Key Event Relationship Description
Histone deacetylase inhibition triggered by histone deacetylase inhibitors such as methoxyacetic acid (MAA) leads to spermatocyte death causing spermatocyte depletion [Wade et al., 2008]. Histone deacetylase inhibition leads to an increase in histone acetylation, leading to spermatocyte apoptosis.
Evidence Collection Strategy
Evidence Supporting this KER
MAA administration induces spermatocyte deaths, which has been revealed by section staining of the germ cell death [Wade et al., 2008].
Biological Plausibility
Histone deacetylase inhibition causes histone acetylation, which increases the gene expression of cell-cyle-related proteins, followed by spermatocyte apoptosis in testis.
Empirical Evidence
Administration of MAA in rats, a histone deacetylase inhibitor (HDI), demonstrated the emergence of TUNEL-positive spermatocytes, which indicates spermatocyte apoptosis [Wade et al., 2008]. Treatment of valproate (VPA) resulted in a decline in the sperm count [Yerby and McCoy, 1999; Kose-Ozlece et al., 2015].
Uncertainties and Inconsistencies
Known modulating factors
Quantitative Understanding of the Linkage
The administration of MAA in rats induced spermatocyte depletion which was confirmed with TUNEL-staining of the germ cells [Wade et al., 2008].
Response-response Relationship
Time-scale
TUNEL-positive germ cells were increased after 8, 12, and 24 hrs of MAA exposure (650 mg/kg i.p.) in the rats [Wade et al., 2008]. TUNEL-positive zygotene spermatocytes have emerged after 12 hrs of MAA exposure in the rats, which was confirmed by the section staining [Wade et al., 2008].
Known Feedforward/Feedback loops influencing this KER
Domain of Applicability
・Histone deacetylase inhibition by histone deacetylase inhibitors caused spermatocyte death in rats. MAA treatment induced spermatocyte death in Sprague-Dawley rats (Rattus norvegicus) [Wade et al., 2008].
・VPA exposure caused a decrease in sperm count in humans (Homo sapiens) [Yerby and McCoy, 1999; Kose-Ozlece et al., 2015].
References
Kose-Ozlece, H. et al. (2015), "Alterations in semen parameters in men wıth epilepsy treated with valproate", Iran J Neurol 14:164-167
Wade, M.G. et al. (2008), "Methoxyacetic acid-induced spermatocyte death is associated with histone hyperacetylation in rats", Biol Reprod 78:822-831
Yerby, M.S. and McCoy, G.B. (1999), "Male infertility: Possible association with valproate exposure", Epilepsia 40:520-521